Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes (Q45881040)

17 December 2017

title

Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes (English)

1 reference

17 December 2017

5

M K Brenner

1 reference

17 December 2017

Jed G Nuchtern

3

object named as

J G Nuchtern

1 reference

17 December 2017

author name string

C Rossig

1

1 reference

17 December 2017

C M Bollard

2

1 reference

17 December 2017

D A Merchant

4

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

17 December 2017

International Journal of Cancer

published in

1 reference

17 December 2017

volume

94

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

228-236

1 reference

17 December 2017

Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma

cites work

1 reference

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

21 January 2018

1 reference

Recognition of human colon cancer by T cells transduced with a chimeric receptor gene

21 January 2018

1 reference

Fas-ligand-mediated lysis of erbB-2-expressing tumour cells by redirected cytotoxic T lymphocytes

21 January 2018

1 reference

Specific targeting of EGP-2+ tumor cells by primary lymphocytes modified with chimeric T cell receptors

21 January 2018

1 reference

Ganglioside composition of human neuroblastomas. Correlation with prognosis. A Pediatric Oncology Group Study

21 January 2018

1 reference

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group

21 January 2018

1 reference

Episomal vectors rapidly and stably produce high-titer recombinant retrovirus

21 January 2018

1 reference

Generation and characterization of a mouse single-chain antibody fragment specific for disialoganglioside (GD2).

21 January 2018

1 reference

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

21 January 2018

1 reference

Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells

21 January 2018

1 reference

T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins.

21 January 2018

1 reference

Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides

21 January 2018

1 reference

Grafting T cells with tumor specificity: the chimeric receptor strategy for use in immunotherapy of malignant diseases

21 January 2018

1 reference

Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors

21 January 2018

1 reference

Efficient discrimination between different densities of target antigen by tetracycline-regulatable T bodies

21 January 2018

1 reference

New anti-GD2 monoclonal antibodies produced from gamma-interferon-treated neuroblastoma cells

21 January 2018

1 reference

T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitope

21 January 2018

1 reference

Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes

21 January 2018

1 reference

Isolation of IgG antibody Fv-DNA from various mouse and rat hybridoma cell lines using the polymerase chain reaction with a simple set of primers

21 January 2018

1 reference

Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor

21 January 2018

1 reference

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma

21 January 2018

1 reference

Quantitation of the density of cell surface carbohydrate antigens on cancer cells with a sensitive cell-suspension ELISA

21 January 2018

1 reference

A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma

21 January 2018

1 reference

Detection of neuroblastoma in bone marrow by immunocytology: is a single marrow aspirate adequate?

21 January 2018

1 reference

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.1457

1 reference

17 December 2017

1 reference

17 December 2017